Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000893220-07-002389
Filing Date
2007-07-10
Accepted
2007-07-10 06:58:16
Documents
5
Period of Report
2006-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A PAR PHARMACEUTICAL COMPANIES, INC. w36847e10vqza.htm 10-Q/A 649636
2 CERTIFICATION BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER w36847exv31w1.htm EX-31.1 8493
3 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER w36847exv31w2.htm EX-31.2 8499
4 CERTIFICATION BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION w36847exv32w1.htm EX-32.1 3975
5 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 906 w36847exv32w2.htm EX-32.2 3831
  Complete submission text file 0000893220-07-002389.txt   675948
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

EIN.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-10827 | Film No.: 07970750
SIC: 2834 Pharmaceutical Preparations